UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Evaluation of a Pharmacist-Developed, Nurse-Driven Protocol for Management of Parenteral Anticancer Therapy Infusion Reactions in an Ambulatory Infusion Center

Journal of oncology pharmacy practice, 2023-06, Vol.29 (4), p.802-809

2023

Volltextzugriff (PDF)

Evaluation of Treatment-Dose Enoxaparin in Acutely Ill Morbidly Obese Patients at an Academic Medical Center: A Randomized Clinical Trial

The Annals of pharmacotherapy, 2019-06, Vol.53 (6), p.567

2019

Volltextzugriff (PDF)

Analysis of Opioid Use Following Curative Cancer Treatment at a Large Urban Safety-net Hospital

The Clinical journal of pain, 2018-10, Vol.34 (10), p.885-889

2018

Volltextzugriff (PDF)

Antibiotic Allergies in the Medical Record: Effect on Drug Selection and Assessment of Validity

Pharmacotherapy, 2008-11, Vol.28 (11), p.1348-1353

2008

Volltextzugriff (PDF)

Opioid prescribing upon discharge for patients with solid malignancies

Journal of clinical oncology, 2018-12, Vol.36 (34_suppl), p.50-50

2018

Volltextzugriff (PDF)

A risk scoring system for African-American (AA) patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line abiraterone (ABA) or enzalutamide (ENZ)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.51-51

2020

Volltextzugriff (PDF)

The real-world efficacy of abiraterone acetate (ABA) and docetaxel (DOC) in the treatment of African-American (AA) patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.52-52

2020

Volltextzugriff (PDF)

Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.956-964

2021

Volltextzugriff (PDF)

Retrospective study evaluating the safety of administering pegfilgrastim on the final day of 5-fluorouracil continuous intravenous infusion

Journal of oncology pharmacy practice, 2021-07, Vol.27 (5), p.1159-1164

2021

Volltextzugriff (PDF)

Adherence to oral anticancer medications after implementation of an ambulatory adherence program at a large urban academic hospital

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6591-6591

2018

Volltextzugriff (PDF)

Retrospective study of the safety of administering pegfilgrastim on the same day of 5- Fluorouracil pump disconnect

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16190-e16190

2018

Volltextzugriff (PDF)

Improving documentation of pain and constipation management within the cancer center of a large public healthcare network

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6596-6596

2018

Volltextzugriff (PDF)

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer

Urologic oncology, 2022-06, Vol.40 (6), p.271.e9-271.e18

2022

Volltextzugriff (PDF)

Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital

JCO oncology practice, 2020-04, Vol.16 (4), p.e350-e356

2020

Volltextzugriff (PDF)

870: EVALUATION OF PROTHROMBIN COMPLEX CONCENTRATE UTILIZATION AT A LARGE, URBAN ACADEMIC MEDICAL CENTER

Critical care medicine, 2014-12, Vol.42, p.A1570

2014

Volltextzugriff (PDF)

Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications

Journal of oncology practice, 2018-07, Vol.14 (7), p.e446

2018

Volltextzugriff (PDF)

PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL

Blood, 2014-08, Vol.124 (9), p.1481-1491

2014

Volltextzugriff (PDF)

A Novel Inhibitor of BET Family Bromodomains Demonstrates In Vivo and I n Vi tro Potency in B-Cell Malignancies

Blood, 2015-12, Vol.126 (23), p.318-318

2015

Volltextzugriff (PDF)

Expression and purification of active human recombinant cathepsin K in E. coli

The FASEB journal, 2010-04, Vol.24 (S1), p.683.7-683.7

2010

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(7)
Oncology
(6)
Male
(5)
Pharmacology & Pharmacy
(4)
Retrospective Studies
(4)
Female
(3)
Middle Aged
(3)
Adult
(2)
Aged
(2)
Castration-Sensitive Prostate Cancer
(2)
Docetaxel - Therapeutic Use
(2)
5-Fu
(1)
Abiraterone
(1)
Academic Medical Centers
(1)
Administration, Oral
(1)
African Americans
(1)
Allergic Reactions
(1)
Allergy History
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of a Pharmacist-Developed, Nurse-Driven Protocol for Management of Parenteral Anticancer Therapy Infusion Reactions in an Ambulatory Infusion Center

Evaluation of Treatment-Dose Enoxaparin in Acutely Ill Morbidly Obese Patients at an Academic Medical Center: A Randomized Clinical Trial

Analysis of Opioid Use Following Curative Cancer Treatment at a Large Urban Safety-net Hospital

Antibiotic Allergies in the Medical Record: Effect on Drug Selection and Assessment of Validity

Opioid prescribing upon discharge for patients with solid malignancies

A risk scoring system for African-American (AA) patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line abiraterone (ABA) or enzalutamide (ENZ)

The real-world efficacy of abiraterone acetate (ABA) and docetaxel (DOC) in the treatment of African-American (AA) patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC)

Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options

Retrospective study evaluating the safety of administering pegfilgrastim on the final day of 5-fluorouracil continuous intravenous infusion

Adherence to oral anticancer medications after implementation of an ambulatory adherence program at a large urban academic hospital

Retrospective study of the safety of administering pegfilgrastim on the same day of 5- Fluorouracil pump disconnect

Improving documentation of pain and constipation management within the cancer center of a large public healthcare network

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer

Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital

870: EVALUATION OF PROTHROMBIN COMPLEX CONCENTRATE UTILIZATION AT A LARGE, URBAN ACADEMIC MEDICAL CENTER

Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications

PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL

A Novel Inhibitor of BET Family Bromodomains Demonstrates In Vivo and I n Vi tro Potency in B-Cell Malignancies

Expression and purification of active human recombinant cathepsin K in E. coli

Suchergebnisse filtern